Skip to main content
Premium Trial:

Request an Annual Quote

Cue Health Nabs CE Mark for Molecular Point-of-Care COVID-19 Test

NEW YORK ─ Cue Health said on Tuesday that it has received the CE mark for its molecular point-of-care COVID-19 test, clearing it for sale in the European Union and other regions that accept the designation.

The nucleic acid amplification test ─ compact enough to fit in the palm of a hand ─ consists of the single-use Cue Test Cartridge and the Cue Sample Wand, a lower nasal swab for sample collection. It runs on the Cue Health Monitoring System and displays test results on a connected mobile device in about 20 minutes via an app. A reusable, battery-operated reader and the cartridge communicate results directly to the health app, the firm said.

San Diego-based Cue added that US-based K-12 schools, essential businesses, hospitals, physicians' offices, dental clinics, nursing homes, and other congregate-care facilities are already using its COVID-19 test. It is also being used in several states under a program led by the US Department of Defense and the US Department of Health and Human Services.

The Scan

Alzheimer's Risk Gene Among Women

CNN reports that researchers have found that variants in MGMT contribute to Alzheimer's disease risk among women but not men.

Still Hanging Around

The Guardian writes that persistent pockets of SARS-CoV-2 in the body could contribute to long COVID.

Through a Little Spit

Enteric viruses like norovirus may also be transmitted through saliva, not just the fecal-oral route, according to New Scientist.

Nature Papers Present Method to Detect Full Transcriptome, Viruses Infecting Asgard Archaea, More

In Nature this week: VASA-seq approach to detect full transcriptome, analysis of viruses infecting Asgard archaea, and more.